•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

J01608 Summary:

BILL NOJ01608
 
SAME ASNo Same As
 
SPONSORRIVERA
 
COSPNSR
 
MLTSPNSR
 
 
Go to top

J01608 Text:

 
Senate Resolution No. 1608
 
BY: Senator RIVERA
 
        MEMORIALIZING  Governor  Kathy  Hochul to proclaim
        June 2026, as Meningitis B Awareness  Month  in  the
        State of New York
 
  WHEREAS,  It  is  the  custom  of  this Legislative Body to increase
awareness of serious illnesses that affect the lives  of  our  citizens;
and
 
  WHEREAS,  It  is  the  sense of this Legislative Body to memorialize
Governor Kathy Hochul to proclaim June 2026, as Meningitis  B  Awareness
in the State of New York; and
 
  WHEREAS,   Meningococcal  disease,  more  commonly  referred  to  as
bacterial meningitis, is any infection caused by the bacterium Neisseria
meningitidis; and
 
  WHEREAS,  Meningococcal  disease  is  uncommon;  however,  when   it
strikes, its flu-like symptoms make diagnosis difficult; and
 
  WHEREAS,  Meningococcal  disease  can  cause serious illness such as
infection of the lining of the brain and spinal column  (meningitis)  or
blood  infections  (sepsis); the disease strikes quickly and can lead to
severe or permanent disabilities, such as hearing  loss,  brain  damage,
seizures, limb amputation or even lead to death within 24-48 hours; and
 
  WHEREAS, Although 1 in 10 people are carriers for this bacteria with
no  signs  or  symptoms  of  disease,  sometimes  Neisseria meningitidis
bacteria can cause illness; and
 
  WHEREAS,  There  are  five  common   serogroups   of   meningococcal
meningitis in the United States, which are serogroups A, B, C, W, and Y,
and multiple vaccines exist to help protect against all five serogroups;
and
 
  WHEREAS,  The  single best way to help prevent all common serogroups
of meningococcal disease is to be vaccinated with both a MenACWY vaccine
and a separate MenB vaccine or with a MenABCWY  vaccine,  if  indicated;
and
 
  WHEREAS,  Meningococcal  disease is spread from person to person via
the exchange of the bacteria through respiratory and  throat  secretions
during  close  or  lengthy  contact, such as sharing beverages or eating
utensils, kissing, or spending time in close contact with someone who is
sick or who carries the bacteria; and
 
  WHEREAS, Community settings in which large groups of people  gather,
like  college  campuses  and  high schools, can increase the risk of the
spread of meningococcal disease; and
 
  WHEREAS, Because of the way  meningitis  is  spread,  through  close
personal  contact,  the  social  behavior  of  young  adults  ages 16-23
increases their risk of contracting the disease; students  in  dormitory
 
settings   and   crowded   events,   are   particularly   vulnerable  to
meningococcal disease; and
 
  WHEREAS,  While  vaccines  for  serogroups  A, C, W, and Y have been
available for  many  years,  prior  to  2014,  there  were  no  vaccines
available for serogroup B; and
 
  WHEREAS,  Despite the existence of a serogroup B vaccine, meningitis
B has been responsible for all U.S. college campus outbreaks since 2011,
with some cases resulting in death; and
 
  WHEREAS, Because protection against serogroup B requires a  separate
vaccination,  students  heading  to college may mistakenly think that if
they received the MenACWY vaccine that they are fully protected  against
all  serogroups  and  may  not  realize  they  are not protected against
serogroup B; and
 
  WHEREAS,  According  to  the  Centers  for   Disease   Control   and
Prevention,  Neisseria  meningitidis serogroup B accounts for 70% of all
meningococcal meningitis cases among persons aged  16-23  years  in  the
United States; and
 
  WHEREAS,  Vaccination  for  serogroups  A,  C,  W and Y is routinely
recommended by the American Academy of Pediatrics; and
 
  WHEREAS,  The  American  Academy  of  Pediatrics   recommends   that
decisions  to vaccinate adolescents and young adults 16 through 23 years
of age against serogroup B meningococcal disease should be made  at  the
individual  level  with  health  care  providers through shared clinical
decision making; and
 
  WHEREAS, In accordance  with  the  American  Academy  of  Pediatrics
recommendations,  Chapter  401  of  the  Laws  of 2015 in New York State
requires that as of September 1, 2016, children in grades 7  and  12  be
immunized against meningococcal disease serogroups A, C, W, and Y; and
 
  WHEREAS,  New York State Public Health Law (NYS PHL) § 2167 requires
institutions,  including  colleges  and  universities,   to   distribute
information  about meningococcal disease and vaccination to all students
meeting the enrollment criteria, whether they live on or off campus; and
 
  WHEREAS, While New York  State  Law  does  not  require  vaccination
against  serogroup  B meningococcal disease, young adults aged 16-23 may
choose to receive the MenB vaccine series, and are encouraged to discuss
the MenB vaccine with a healthcare provider; and
 
  WHEREAS, Meningitis vaccines  are  covered  by  public  and  private
insurance  plans, and individuals are encouraged to contact their health
insurance plan to determine coverage of MenACWY and MenB vaccines; and
 
  WHEREAS, The Federal Vaccines for Children (VFC)  and  NYS  Vaccines
for  Adults (VFA) programs will cover both MenACWY and MenB vaccines for
children and adults  who  have  no  health  insurance  or  whose  health
insurance  does  not  cover these vaccines, as well as for children less
than 19 years of age  who  are  American  Indian  or  Alaska  Native  or
eligible for Medicaid or Child Health Plus; and
 
  WHEREAS,  Kimberly  Coffey  was  17 and a high school senior on Long
Island, who had been vaccinated with the MenACWY vaccine, when she  died
from  meningitis  B in 2012, two years before meningitis B vaccines were
available in the United States; and
 
  WHEREAS,  Kimberly's  mother,  Patti  Wukovits,  R.N.,  created  the
Kimberly Coffey Foundation and today, this  vital  organization  remains
true to its mission in providing education to the public and health care
professionals  about  meningococcal disease and advocating for two types
of meningococcal vaccination; and
 
  WHEREAS, The Kimberly Coffey Foundation's goal is to ensure that  no
other  family  will  endure  the  loss  of  a  child or have a loved one
experience the devastating effects of meningococcal disease; and
 
  WHEREAS, June 15, 2026, marks the fourteenth anniversary of Kimberly
Coffey's death; and
 
  WHEREAS, Students, parents, educators and health care providers need
to know about all serogroups of  meningococcal  meningitis  and  how  to
protect against all serogroups; and
 
  WHEREAS,  A Meningococcal Disease Fact Sheet is available on the New
York State Department of Health website; and
 
  WHEREAS, June is a time when students are preparing to go to college
and can discuss how to become fully vaccinated with  their  health  care
provider; now, therefore, be it
 
  RESOLVED,  That  this Legislative Body pause in its deliberations to
memorialize Governor Kathy Hochul to proclaim June 2026, as Meningitis B
Awareness Month in the State of New York; and be it further
 
  RESOLVED, That copies of this  Resolution,  suitably  engrossed,  be
transmitted  to The Honorable Kathy Hochul, Governor of the State of New
York; and Patti Wukovits,  R.N.,  Executive  Director  of  the  Kimberly
Coffey Foundation.
Go to top